ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

Author(s):
Luchini, C.; Bibeau, F.; Ligtenberg, M.J.L.; Singh, N.; Nottegar, A.; Bosse, T.; Miller, R.; Riaz, N.; Douillard, J.Y.; Andre, F.; Scarpa, A.
Published
2019
Publication type
Article / Letter to editor
microsatellite instability (MSI)tumour mutational burden (TMB)tumour mutational load (TML)next-generation sequencing (NGS)immunotherapy
Date issued
2019-08-31
Language
English
Is part of
Annals of Oncology (2019), Vol. 30, no. 8, p. 1232-1243
hdl
1887/121019
doi
10.1093/annonc/mdz116